Sign in to continue:

Thursday, July 30th, 2026

伊之密第一期员工持股计划完成回购股份非交易过户,持股比例及实施进展公告

伊之密股份有限公司第一期员工持股计划完成回购股份非交易过户,股权激励进一步推进

重要事项概述

  • 伊之密股份有限公司(300415)于2026年5月12日召开的2025年年度股东会批准实施第一期员工持股计划。
  • 截至公告披露日,员工持股计划已完成公司回购股份的非交易过户,具体为900,440股,约占公司当前总股本的0.19%。
  • 本次员工持股计划的股票来源均为公司通过二级市场集中竞价方式回购所得A股普通股。
  • 员工持股计划资金来源为公司依据中长期激励管理办法提取的2025年TUP总包,实际资金总规模2,308.73万元,份额为2,308.73万份。
  • 本次购股价格为每股25.64元。
  • 员工持股计划累计持股不超过公司总股本的10%,任一参加对象持有份额对应股票不超过总股本的1%。
  • 员工持股计划参与对象包含部分董事与高管,但高管与董事未担任持股计划管理委员会职务,员工持股计划与5%以上股东、高管、董事不存在一致行动关系。
  • 员工持股计划成本及摊销将根据会计准则进行确认,对公司经营业绩的影响以审计结果为准。

对投资者和股东的影响

  • 股权激励落地:员工持股计划实际落地,进一步绑定核心管理团队与员工利益,有助于提升公司治理与运营效率,增强员工凝聚力,对公司中长期发展具有积极意义。
  • 股份稀释影响有限:本次非交易过户股份仅占总股本的0.19%,对现有股东持股比例影响较小。
  • 资金来源与风险:员工持股计划全部资金均为公司自有资金及TUP激励计提,不涉及外部融资、杠杆或公司为员工提供担保,风险可控。
  • 管理层激励机制优化:高管及董事虽为持股计划对象,但未参与管理委员会或一致行动安排,有效防范利益冲突。
  • 会计与业绩影响:相关成本摊销将根据会计准则分期计入费用与资本公积,对业绩具体影响需以后续审计结果为准。
  • 后续信息披露:公司承诺将持续披露员工持股计划进展,提醒投资者关注相关风险。

细节补充

  • 回购股份来源包括两次回购方案,分别于2023年10月及2025年4月启动,累计回购股份总额及资金分别为8,000,167股、1.43亿元(2023年方案)与973,251股、2,000万元(2025年方案)。
  • 员工持股计划专用证券账户名称为“伊之密股份有限公司—第一期员工持股计划”,账户号0899546169。
  • 本次非交易过户已获得中国证券登记结算有限责任公司深圳分公司出具的《证券过户登记确认书》,法律手续完备。
  • 员工持股计划股票不包含员工通过IPO前持有、二级市场自行购买及股权激励获得的股份。

投资者需重点关注

  • 本次公告为员工持股计划正式落地,属于公司治理及激励体系的重要进展,短期对公司股价或有情绪提振作用。
  • 员工持股计划未来的行权、解锁及对应的业绩要求、服务年限等,将影响实际激励效果及公司经营表现,建议持续关注后续披露。
  • 公司回购股份用于员工激励,有望提升公司凝聚力与竞争力,具备中长期利好预期。

免责声明:本文基于伊之密股份有限公司公告内容整理,仅供投资者参考,不构成投资建议。股市有风险,投资需谨慎。

Yizumi Co., Ltd. Completes Non-Trading Transfer of Repurchased Shares for First Phase Employee Stock Ownership Plan

Key Highlights

  • Yizumi Co., Ltd. (300415) held its 2025 Annual General Meeting on May 12, 2026, approving the implementation of its first phase employee stock ownership plan (ESOP).
  • As of the date of the announcement, the ESOP has completed the non-trading transfer of 900,440 shares repurchased by the company, accounting for approximately 0.19% of the current total share capital.
  • The shares for the ESOP were all acquired via company buy-backs on the secondary market through centralized bidding.
  • The ESOP is funded completely from the company’s own funds, specifically the 2025 TUP incentive accrual, totaling RMB 23.0873 million, with 23.0873 million units allocated.
  • The purchase price for the shares was RMB 25.64 per share.
  • Total shares held by all ESOPs will not exceed 10% of the company’s total share capital, and any individual participant’s holding will not exceed 1% of the total share capital.
  • Participants include some directors and senior management, but these individuals do not serve on the management committee of the ESOP and there is no concerted action agreement among them.
  • Costs and amortization of the ESOP will be recognized per accounting standards, and the impact on company performance will depend on future audit results.

Implications for Investors and Shareholders

  • Implementation of Equity Incentive: The ESOP’s actual implementation further aligns the interests of key management and employees with shareholders, boosting company governance and operational efficiency, and supporting long-term development.
  • Limited Dilution: The transferred shares represent only 0.19% of total share capital, so the impact on existing shareholders’ holdings is minimal.
  • Funding and Risk: The ESOP is entirely funded by company accruals, with no external leverage, guarantees, or financing, keeping risks controllable.
  • Improved Incentive Structure: While directors and senior managers participate in the ESOP, they do not manage it nor act in concert, reducing conflict of interest.
  • Accounting and Performance Impact: ESOP costs will be expensed and allocated per Chinese accounting standards, with the final impact subject to audited results.
  • Ongoing Disclosure: The company promises to keep investors updated on ESOP progress and reminds investors to monitor related risks.

Additional Details

  • The repurchased shares come from two buy-back programs initiated in October 2023 and April 2025, involving a total of 8,000,167 shares (RMB 143 million) and 973,251 shares (RMB 20 million) respectively.
  • The ESOP’s dedicated securities account is “Yizumi Co., Ltd. – First Phase Employee Stock Ownership Plan,” account number 0899546169.
  • The non-trading transfer has been formally confirmed by China Securities Depository and Clearing Corporation’s Shenzhen branch.
  • The ESOP does not include shares acquired by employees before the IPO, via secondary market purchases, or through other equity incentive programs.

Key Points for Investors

  • This announcement marks the formal launch of the ESOP, a crucial step in corporate governance and employee incentive, which may have a positive short-term impact on the stock price.
  • The future unlocking of the ESOP, performance requirements, and service periods will affect the actual incentive effect and operating results; investors should follow subsequent disclosures closely.
  • The use of repurchased shares for employee incentive is expected to enhance cohesion and competitiveness, with positive long-term prospects.

Disclaimer: This article is based on the official announcement from Yizumi Co., Ltd. and is for investor reference only. It does not constitute investment advice. The stock market carries risk; invest cautiously.

View 伊之密 Historical chart here



山东联科科技2025年度权益分派实施公告:每10股派5元现金红利及4股转增方案详解

联科科技发布2025年度权益分派实施公告,现金分红与转增股本提升投资吸引力 联科科技发布2025年度权益分派实施公告...

*ST高斯贝尔2025年度股东会决议公告:议案表决结果与董事会换届详情

*ST高斯贝尔2025年年度股东会决议公告详解:多项议案高票通过,董事会换届完成,关联交易及担保事项受关注 高斯贝尔...

中粮生物科技股份有限公司2026年第一季度财报:营收下降11.55%,净利润亏损1.21亿元

中粮生物科技2026年第一季度业绩详细解读 中粮生物科技2026年第一季度业绩详细解读 一、业绩表现亮点与关键数据 ...